glutathione inhibitor clinical trial

glutathione inhibitor clinical trial Development of potent transferase Omega-1 inhibitors with applications in inflammation and cancer therapy Glutathione determines chronic myeloid leukemia

Name: glutathione inhibitor clinical trial Development of potent transferase Omega-1 inhibitors with applications in inflammation and cancer therapy Glutathione determines chronic myeloid leukemia
Brand: dynamiccapital.ca
SKU: 36463135652
Price: 27.28 USD
Availability: InStock
Rating: 4.8181 (28 reviews)

Glutathione determines chronic myeloid leukemia vulnerability to an inhibitor of CMPK and TMPK Communications Biology Targeting gamma glutamyl transpeptidase: A pleiotropic enzyme involved in glutathione metabolism and in the control of redox homeostasis ScienceDirect The glutathione synthesis inhibitor buthionine sulfoximine synergistically enhanced melphalan activity against preclinical models of multiple myeloma Blood Cancer Journal Glutathione Mediated Conjugation of Anticancer Drugs: An Overview of Reaction Mechanisms and Biological Significance for Drug Detoxification and Bioactivation

SKU: 36463135652 · From dynamiccapital.ca

4.8

USD27.28 USD60.28

Pay in 4 interest-free payments of $6.82 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Jul 29 - Aug 3

Description

Nat Commun 7:11321 Lukey MJ, Cluntun AA, Katt WP et al (2019) Liver-type glutaminase GLS2 is a druggable metabolic node in luminal-subtype breast cancer